RespireRx Phamaceuticals
Glen Rock
About RespireRx Phamaceuticals
RespireRx Pharmaceuticals Inc. is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable. All of the Company’s current efforts are involved with sleep apnea/hypopnea, respiratory depression and respiratory distress.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.7M
- Funding stage: IPO
- Last round: Grant (Sep 2025)
- Ticker: otcqb:RSPI
- Website: respirerx.com
- Phone: +1 (917) 834-7206
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/respirerx-phamaceuticals-182268 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.